RE: Valirx Going Forwards7 Nov 2021 19:22
I lurk on the NCYT board but don't participate in the constant bickering. I thought you were a good advocate for the case based on fundamentals, so find the flagrant pumping here to be worthy of slating and has turned my opinion of you. As far as I can see your DMs are blocked but we've had no previous interactions on Twitter. So you can open that up and I'll happily declare myself in DMs.
This company seems to be on a positive trajectory but that doesn't mean it's immune to pump and dumps, so when I saw the tone and substance of your posts I chose not to invest here. I do my own research and make my own decisions, so if the SP stabilises I might invest here too. I tend to look at convictions based on portfolio percentage. Maybe you just took your capital out and left your profits, maybe you are the one living in the brick house or perhaps your name was honest and you're telling porkies. Can't really tell. I just think it's a bad look to be so bullish that you start singalongs and at the first opportunity you are off to other boards to pump there instead.
"Terrific Tuesday – 74p to 85p Inbound 02 Nov 2021 01:33
...
I’m allowing for the fact that Share Prices don’t go up in straight lines, I’m allowing for traders and bedwetters with their fingers on the sell button taking small gains but I’m predicting for a BIG blue day today. At least a 9p ADD today if not more and climbing this week towards that 74-85p range.
...
To get to peer average in one hit we would have to add +36% today from 54p. Not impossible, we would head the leader’s board. The valuation here is like a coiled spring, you really can’t hold it down much longer before we absolutely explode to new heights.
Either way, we are going onto that 74p to 85p range as minimum, watch this space
...
IMO for what its worth, in the Biotech space if they get it right, the valuation’s just skyrocket. With Valirx, I don’t think its just a case of getting right once, I think we have a high chance of 201, 301 and 401 ultimately securing licensing. Three times over, wouldn’t that be something…."
Less than 8 hours later ...
"Really Disappointed 02 Nov 2021 09:14
Well I'm not seeing the same as some of you that's for sure.
I can’t draw breath this morning regarding this deal, they have basically sold the Crown Jewels from under us to a US Start up.
A low back end deal worth potentially $61m so let’s call it £44m, imo a token arrangement."
One of three projects secures minimum payout on success of more than the MCap (with additional £20+M per oncology indication) and frees up more resources at VAL to push other projects. But who's to know, really, as there are a lot of unknowns still. That's where the faith and trust in Suzy should have come in, but maybe there were some porkies about that too.